Given GIPs clear ability to act as the most important incretin hormone, it is surprising that it also augments glucagon secretion
Adding a second incretin mimetic doubles the exposure to a drug class with this warning, with no data to characterize the incremental risk magnitude
Hims & Hers' weight loss business continues to be a major focus for the company, and that segment is on pace to bring in $725 million in revenue in 2025, Yemi Okupe, Hims & Hers' chief financial officer, said during the Q3 call with investors in early November
The NEJM phase 2 obesity trial reports published retatrutide study design, dose groups, and safety findings
The GLP-1R agonist liraglutide has also received regulatory approval for the treatment of obesity and conferred protection in an obesity-associated animal model of cardiomyopathy (12)
This hormone is released after eating and plays an important role in regulating blood sugar and appetite